Navin Fluorine International Q1 FY27 Share Price & Earnings Call Analysis

₹8,260.50-2.83% today
Market cap
₹42,388 Cr
P/E
53.31
ROE
19.64%
PEG
2.56
Price to sales
11.67
Debt to equity
0.32
52W high / low
₹8,776 / ₹4,977
Sales growth (5Y)
22.95%
EBITDA margin
33.90%
Net profit margin
19.56%
Promoter holding
27.08%
Sales (last year)
₹3,634 Cr

Navin Fluorine International Ltd is primary engaged in producing refrigeration gases, inorganic fluorides, specialty organofluorines and offers contract research and manufacturing services.[1] Its portfolio includes 50+ fluorinated compounds developed over the years.[2]

Guidance scorecard · Q1 FY27 call

What Navin Fluorine International Ltd's management guided
and where it ranks in Chemicals & Petrochemicals

#14of 71 in
Chemicals & Petrochemicals

RevenueQ1 FY27 call

20–40%
  • Growth till FY '28 is largely baked in due to ongoing capex, including new HFC capacity, debottlenecking plant, and Chemours project.
  • Advanced materials vertical is being incubated to become a material business unit by the decade's end, focusing on high-growth sectors like data centers, electronics, defense, and semiconductors.
  • Specialty chemicals expected to grow with good order visibility and ramp-up in existing/new molecules, despite pricing pressures, especially in Latin America.
  • CDMO business shows strong momentum with an expanding portfolio of commercial, late-stage, and early-stage programs across therapeutic areas including oncology, respiratory, cardiovascular, neurology, and animal health.
  • New molecule pipeline of 30-40 molecules under active development, with 3-4 molecules expected FDA readouts in 8-12 months.

2 more points from Navin Fluorine International Ltd's call on revenue

Create a free account to keep reading this call

Full Q1 FY27 analysis

MarginsQ1 FY27 call

Flat

See what Navin Fluorine International Ltd said on margins — free account, 30 seconds.

Full Q1 FY27 analysis

CapexQ1 FY27 call

Planned
  • INR 90 crores capex approved for setting up adoption capacities for the advanced materials business, funded through internal accruals. This will cater to indigenous products for emerging sectors like data centers, electronics, defense, and semiconductors.…
  • Chemours project as part of advanced materials vertical, targeted for completion by end of Q2 FY '27.
  • Phase 2 cGMP4 capex of INR 125 crores in CDMO business funded through internal accruals, expected operationalization by Q4 FY '27. Part of INR 288 crores cGMP4 capex approved earlier.
  • HFC capacity expansion equivalent to 15,000 metric tons of R32 on track for commissioning in Q3 FY '27.
  • MPP facility debottlenecking at Dahej expected to complete by Q3 FY '27.

2 more points from Navin Fluorine International Ltd's call on capex

Create a free account to keep reading this call

Full Q1 FY27 analysis

FundraisingQ1 FY27 call

See what Navin Fluorine International Ltd said on fundraising — free account, 30 seconds.

Full Q1 FY27 analysis

Order bookQ1 FY27 call

  • Navin Fluorine is actively working on a molecule pipeline of 30 to 40 molecules.
  • About 10 molecules are in the late stage, with 3 to 4 expected to have FDA readouts in the next 8 to 12 months.
  • The company has strong order visibility in the Specialty Chemicals segment with existing and new molecules.
  • CDMO business shows improved visibility with a robust product pipeline and sustained momentum.
  • New capacity for CDMO is dedicated to existing European CDMO partner, with expansion in supply chain participation through MSAs.
  • The company also has upcoming orders related to DRDO, but details remain confidential.

2 more points from Navin Fluorine International Ltd's call on the order book

Create a free account to keep reading this call

Full Q1 FY27 analysis

Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.

Potential multibaggers · Q2 FY27

Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance

  1. 2
  2. Strong growth
    1
  3. Strong growth
    3

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Chemicals & Petrochemicals companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Up 0–2%₹263 Cr3.4
240%+Flat₹4,375 Cr83.7
340%+Flat₹3,259 Cr4.0
440%+Flat₹145 Cr15.9
520–40%Up 2%+₹1.81L Cr90.9
620–40%Up 2%+₹48,366 Cr78.3

Sign up free to see every company in the sector ranking and track Navin Fluorine International Ltd.

Pro shows every company guiding 40%+ revenue growth →Full Chemicals & Petrochemicals ranking

Navin Fluorine International Ltd announcements

All announcements →

Financials of Navin Fluorine International Ltd

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Navin Fluorine International Ltd

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +697491472500602524519606701725758892938
Expenses +495377373424492423411459522519512585617
Operating Profit2021149876110100107147179207246308321
OPM %29%23%21%15%18%19%21%24%26%29%32%34%34%
Other Income +48236413101110121418-531
Interest14192018171614202830302829
Depreciation8212425262728303535373641
Profit before tax184827797796877108127155198238282
Tax %26%25%22%20%11%25%23%23%25%24%25%22%25%
Net Profit +1366261787051598495117148185213
EPS in Rs27.5012.4112.2215.7414.1910.3211.8616.8619.1523.6228.9636.1841.48

Financials of Navin Fluorine International Ltd

Profit & Loss

Annual income statement trend

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +5926807429139961,0621,1791,4532,0772,0652,3493,314
Expenses +5195615826937777948701,0981,5271,6661,8162,232
Operating Profit721181592202192683093565503995341,082
OPM %12%17%21%24%22%25%26%24%26%19%23%33%
Other Income +2923558834299438361074459
Interest34311222287578118
Depreciation20223040283744486396119149
Profit before tax78116182266224258358344496336380873
Tax %26%28%25%32%34%-56%31%24%24%19%24%24%
Net Profit +5884137180149409258263375270289664
EPS in Rs11.1817.0827.8836.4330.1582.5752.0253.0975.6854.5658.19129.46
Dividend Payout %29%25%23%27%26%13%21%21%16%27%12%12%

Financials of Navin Fluorine International Ltd

Balance Sheet

Capital structure and asset base

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital101010101010101010101010
Reserves5786368259741,0631,4021,6241,8342,1752,3732,6163,964
Borrowings +6182191341251218611,3681,4661,272
Other Liabilities +2032283242592312152394204846267381,133
Total Liabilities8529551,1771,2561,3071,6291,8982,3853,5294,3774,8306,379
Fixed Assets +2743755614284305295405561,6461,8752,7363,324
CWIP60201720393995742279711355143
Investments17117023942842719599118444954801,229
Other Assets +3463903603804108661,1639691,5611,2961,2591,683
Total Assets8529551,1771,2561,3071,6291,8982,3853,5294,3774,8306,379

Financials of Navin Fluorine International Ltd

Cash Flows

Operating, investing and financing cash movement

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +176921699015723775-64750571894
Cash from Investing Activity +3-53-16-136-2485-237-172-656-1,094-511-1,235
Cash from Financing Activity +-21-17-67-39-68-81-4542658336-47344
Net Cash Flow-17610-6-3161-45-56-61-8133
Free Cash Flow-6158-841212959147-501-819724404
CFO/OP28%87%78%100%74%76%71%43%8%196%122%83%

Financials of Navin Fluorine International Ltd

Ratios

Working capital efficiency and return ratios

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days748168626375889099919083
Inventory Days968913611091127129149197150117118
Days Payable113112949258797785103122118140
Cash Conversion Cycle575711080961231401541931198961
Working Capital Days393744358881131091404525178
ROCE %11%17%22%29%21%21%22%19%20%11%12%21%

Guidance history

How Navin Fluorine International Ltd's guidance has moved, call by call

CallRevenueMarginsCapexFundraisingOrder book
Q1 FY27 call →20–40%FlatPlanned——
Q4 FY26 call →20–40%FlatPlanned—Rising
Q3 FY26 call →20–40%FlatPlanned—Rising
Q2 FY26 call →40%+Up 2%+PlannedNone plannedRising

What management guided on each call, newest first. Not investment advice, and not a forecast of returns.

82out of 100

Momentum score · price trend

82 out of 100 — Strengthening

Over the past year its share price has done better than most of the stocks we track.

PeriodShare price changeBetter than … of 1,910 stocks
Last 12 months+65.9%89%
Last 6 months+21.1%75%
Last 3 months+11.8%81%
How we calculate it

“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).

The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Navin Fluorine International Ltd: 0.4 × 89 + 0.4 × 75 + 0.2 × 81 = 82.

Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.

Full methodology →

This describes only how the share price has moved up to 29 Oct 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.

Others in Chemicals & Petrochemicals this season

  • Deepak Nitrite Ltd (Q2 FY27)

    Q2 FY27 total revenue: ₹3,091 crore, up 61% YoY (Page 1, 4, 5, 6, 10, 11) . Key investor presentation takeaways from Deepak Nitrite Ltd's Q2 FY27 investor prese

  • Privi Speciality Chemicals Ltd (Q2 FY27)

    19,239.47 lakhs (approximately 33.9% growth). Key results statement takeaways from Privi Speciality Chemicals Ltd's Q2 FY27 results statement — and how it ranks

  • NOCIL Ltd (Q2 FY27)

    427 crores . Key investor presentation takeaways from NOCIL Ltd's Q2 FY27 investor presentation — and how it ranks against sector peers.

  • Neochem Bio Solutions Ltd (Q2 FY27)

    Revenue from Operations for H1 FY27: ₹68.9 crores, up 50% YoY (from ₹45.8 crores in H1 FY26) [Page 22] . Key investor presentation takeaways from Neochem Bio So